Release Testing

Coriolis Pharma offers GMP release testing services to ensure your drug products meet the highest quality, safety and efficacy standards before reaching the clinic or the market. Our scientific expertise and advanced technologies guarantee reliable and accurate testing, supporting your regulatory compliance and product release requirements.

Release Testing Tailored to Your Needs

We provide tailored release testing strategies to meet the specific needs of your drug product, ensuring it adheres to stringent quality control standards and regulatory requirements.

Our comprehensive release testing services include:

Identity Testing

Confirming the identity of the active pharmaceutical ingredient (API) and other key components.

Purity Testing

Assessing the purity of the products and detecting any impurities or related substances.

Potency & Bioactivity

Determining the concentration and potency of the active ingredient.

Physical Testing

Physical testing includes appearance, color, clarity, osmolality, moisture content and subvisible particles/particulate matter.

Specific Tests

Specific tests include peptide mapping, aggregation (by analytical ultracentrifugation or high-performance size-exclusion chromatography) and charge variants (by capillary gel electrophoresis or exchange chromatography).

Surfactant Analysis

Quantitative and qualitative analysis of surfactants.

Visual Inspection

Ensuring the appearance of the drug product meets specified standards.

Analytical Method Development, Qualification and Validation

For common sample types, we can often apply standardized methods with little setup effort. However, when needed, our experienced analytical experts create or optimize custom methods tailored to your active pharmaceutical ingredient, product type and development phase.

Method Development

Our method development approach tailors sample preparation, method settings and data analysis to the needs of your project and sample.

We include representative samples and, where available, suitable reference standards and stressed/degraded materials, allowing our analytical scientists to design a highly suitable, stability-indicating, robust and repeatable method. Upon request, we will compile a detailed description of the method for your records.

Method Qualification

Method qualification is the initial assessment of an analytical procedure’s performance to show its suitability for its intended purpose.

During method qualification, our analytical scientists perform documented testing demonstrating that the analytical procedure meets criteria in several categories. Criteria may include factors such as repeatability, specificity and robustness. We compile a qualification plan and report, including all relevant data.

Method Validation

Under GMP conditions, method validation confirms that an analytical procedure’s performance suits its intended purpose. Depending on the method’s scope, a broad range of method characteristics, such as specificity, accuracy, precision, limit of detection/limit of quantification (LOD/LOQ), linearity and range, is considered.

During method validation, our analytical scientists perform documented testing demonstrating that the analytical procedure consistently produces a result that meets the predetermined acceptance criteria. We compile a validation plan and report that includes all relevant data.

Depending on the development phase, a fit-for-purpose validation approach can be offered, adjusting the validation required efforts in a phase-appropriate way to meet the method’s needs.

Method Verification

Compendial method verification confirms that a compendial method (e.g., from Ph. Eur. or USP) is suitable and reliable for its intended purpose under the specific conditions of the laboratory.

Unlike full method validation, compendial method verification is often considered a partial validation since the method has already undergone extensive testing and validation during its inclusion in the compendium. The extent of method verification depends on the type of method.

During method verification, our analytical scientists perform documented testing demonstrating that the developed analytical method performs adequately for the specific product or matrix being tested and within the specific laboratory where the method will be employed.

We’ve worked with more than 930 compounds, and that number is growing by the day.

Release Testing for Your Drug Product

Coriolis Pharma’s deep expertise across many biologic modalities for drug product–specific release testing under GMP conditions ensures reliable testing results of your clinical or commercial drug product. We offer those services in close collaboration with our clients or their CDMOs. We are open to being an integral part of quality control/qualified person (QC/QP) release testing of CDMOs. We are regularly audited by our clients and inspected by our responsible authority.

Your Phase

Our expert team has the expertise and experience to guide your drug product development program from preclinical and early-phase development to the market.

Coriolis Effect

See how our expertise and comprehensive services accelerate biologics development from preclinical to the market.

Release Testing Resources

View All

Talk to Our Experts or Request a Quote

Our expert team is ready to answer your questions and guide you to the services best suited to your program’s modality, stage and challenge. If your needs are well-defined, we’ll begin the quotation process.

Description